Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of dupilumab in atopic comorbidities associated with moderate‐to‐severe adult atopic dermatitis
Eustachio Nettis, Vincenzo Patella, Carla Lombardo, et al.
Allergy (2020) Vol. 75, Iss. 10, pp. 2653-2661
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Dupilumab: A Review of Present Indications and Off-Label Uses
Francisco J. Muñoz‐Bellido, Esther Moreno, Ignacio Dávila
Journal of Investigational Allergology and Clinical Immunology (2021) Vol. 32, Iss. 2, pp. 97-115
Open Access | Times Cited: 94
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
Masahiro Kamata, Yayoi Tada
JID Innovations (2021) Vol. 1, Iss. 3, pp. 100042-100042
Open Access | Times Cited: 56
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Matthew F. Wipperman, Kaitlyn Gayvert, Amanda Atanasio, et al.
Allergy (2024) Vol. 79, Iss. 4, pp. 894-907
Open Access | Times Cited: 12
Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study
Eustachio Nettis, Silvia Ferrucci, Michela Ortoncelli, et al.
Journal of Investigational Allergology and Clinical Immunology (2020) Vol. 32, Iss. 2, pp. 124-132
Open Access | Times Cited: 54
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
Jonathan Corren, Sarbjit S. Saini, Rémi Gagnon, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 1045-1063
Open Access | Times Cited: 50
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
Eustachio Nettis, Luisa Brussino, Vincenzo Patella, et al.
Clinical and Molecular Allergy (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis
Anju T. Peters, Martin Wagenmann, Jonathan A. Bernstein, et al.
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 4, pp. 265-274
Open Access | Times Cited: 17
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis
Corrado Pelaia, Nicola Lombardo, Maria Teresa Busceti, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 1165-1172
Open Access | Times Cited: 39
Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities
Dea Metko, Maha Alkofide, Mohannad Abu‐Hilal
JAAD International (2024) Vol. 15, pp. 5-11
Open Access | Times Cited: 5
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 4, pp. 988-1009
Open Access | Times Cited: 37
Future of allergic rhinitis management
Sophia Linton, Alyssa G. Burrows, Lubnaa Hossenbaccus, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 127, Iss. 2, pp. 183-190
Closed Access | Times Cited: 32
Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study
Kexin Zhao, Ge Yang, Xiyuan Zhou, et al.
Dermatitis (2025)
Closed Access
The role of ILC2s in asthma combined with atopic dermatitis: bridging the gap from research to clinical practice
Yang Luo, Yu Deng, Feng Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real‐life study up to 36 weeks
Luca Mastorino, Vania L. CANTAFIO DUÒ, Cristina VECCO, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 15
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
Tiago Torres, Maria João Paiva Lopes, Margarida Gonçalo, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2554-2559
Closed Access | Times Cited: 12
Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
Amanda Atanasio, Jamie Orengo, Matthew A. Sleeman, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 12
The efficacy and safety of dupilumab for the treatment of atopic dermatitis among Chinese patients in clinical practice: A single‐center retrospective study
Ying Li, Jiajing Lu, Rongfen Chen, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 5
Open Access | Times Cited: 8
An Observational Study of Early Treatment Response and Predictors of Dupilumab in the Treatment of Moderate‐to‐Severe Atopic Dermatitis
Sisi Deng, Huan Wang, Jiong Fu, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Single-Domain Antibodies—Novel Tools to Study and Treat Allergies
Ines Zettl, Clarissa Bauernfeind, Jessica Kollárová, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7602-7602
Open Access | Times Cited: 1
Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment
Erminia Ridolo, Francesca Nicoletta, Carlo Lombardi, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 10, pp. 100968-100968
Open Access | Times Cited: 1
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
Marco Dubini, Valentina Benzecry, Federica Rivolta, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 2
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
J Rodríguez, E. Serra‐Baldrich, Ricardo Ruíz‐Villaverde, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv12314-adv12314
Open Access | Times Cited: 2
Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China
Sisi Deng, Huan Wang, Qiquan Chen, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 6
Closed Access
Page 1 - Next Page

Scroll to top